SCHEMBL10185800

SCHEMBL10185800

CC(C)(C)OC(=O)N1CCN(c2cc(-c3cc(Cl)ccc3OCc3ccccc3)ccn2)CC1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GRM5 P41594 1/20 0.52
ALDH1A1 P00352 2/20 0.48
LMNA P02545 1/20 0.48
MAPT P10636 1/20 0.48
TSHR P16473 1/20 0.48
HTT P42858 1/20 0.48
SMN1; SMN2 Q16637 1/20 0.48
ACHE P22303 1/20 0.47
TLR9 Q9NR96 3/20 0.47
TLR7 Q9NYK1 2/20 0.47
CCNT1 O60563 1/20 0.47
CCNA2 P20248 1/20 0.47
CDK2 P24941 1/20 0.47
CDK9 P50750 1/20 0.47
CCNA1 P78396 1/20 0.47
CKS1B P61024 2/20 0.46
SKP1 P63208 2/20 0.46
SKP2 Q13309 2/20 0.46
ALK Q9UM73 1/20 0.45
CYP2C9 P11712 3/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL322569 0.88 GRM5 (0.57) GRM5ALDH1A1LMNAMAPTTSHR
SCHEMBL10185799 0.86 ALK (0.48) ACHETLR9TLR7CCNT1CCNA2
SCHEMBL1094651 0.82 SMARCA2 (0.46) ALDH1A1CKS1BSKP1SKP2CYP2C9
SCHEMBL29157436 0.79 LRRK2 (0.54) ALDH1A1LMNATSHRHTTSMN1; SMN2
SCHEMBL3443191 0.79 CKS1B (0.64) ACHECKS1BSKP1SKP2ALK
SCHEMBL3164551 0.78 GPR119 (0.54) GRM5ACHECKS1BSKP1SKP2
SCHEMBL31181020 0.76 CKS1B (0.54) ACHETLR9TLR7CCNT1CCNA2
SCHEMBL322608 0.75 PTGER1 (0.49) GRM5ACHECYP2C9PTGER1
SCHEMBL4925908 0.75 TLR9 (0.49) ACHETLR9TLR7CCNT1CCNA2
SCHEMBL5339319 0.74 HTR1A (0.55) ALDH1A1ACHETLR9TLR7CKS1B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2590951-B1 BENZENESULFONAMIDES USEFUL AS SODIUM CHANNEL INHIBITORS PFIZER LTD (GB) 2015-01-07 EP disclosed
US-8772293-B2 Chemical compounds PFIZER LIMITED (GB) 2014-07-08 US disclosed
US-8772293-B2 Chemical compounds PFIZER LIMITED (GB) 2014-07-08 US disclosed
WO-2012004743-A1 BENZENESULFONAMIDES USEFUL AS SODIUM CHANNEL INHIBITORS PFIZER LIMITED (GB) 2012-01-12 WO disclosed
US-20120010182-A1 Chemical Compounds ICAGEN INC. (US) 2012-01-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120010182-A1 Chemical Compounds SCN1A, SCN1B, CACNA1E GRM5 1249/4885ALDH1A1 557/4885LMNA 2825/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.